Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CNSI Cambridge Neuroscience -- Ignore unavailable to you. Want to Upgrade?

To: Cheryl Galt who wrote (637)	3/8/2001 9:21:00 AM
From: limit	Read Replies (2) \| Respond to of 675

Do you guys have your shares yet? This is what my broker sent me. Does this make sense? Dear Client, I checked with our reorg. dept. The information on the take over is the terms are not definite but they intend to exchange between $.9586 - $1.3915 per share of CNSI to automatically purchase an ordinary share of Cene Pharmaceuticals. The problem is these shares will not be trading on any US exchange nor did they indicate any ADRs to trade. They have not given a date when the shares will be sent to brokers to show in the account. The exchange agent is Lloyds of London. They gave a number in their announcement to brokers of 44-190-370-2099. This is to London. They also gave a number for CNSI to call of 781-255-6700. This is all the information supplied to us from the company. Sincerely, Scottrade